Prosta Fink Forte(r) in the Therapy of Benign Prostatic Hyperplasia. Multicentric Surveillance Study in 2,245 Patients Objective and Design:Therapeutic use and safety of a pumpkin seed extract were tested in a multicentric clinical trial. Patients and Methods:2,245 patients suffering from benign prostate hyperplasia (stage I to II according to Alken) received for 12 weeks 1–2 capsules Prosta Fink Forte per day. Urinary symptoms were recorded by the International Prostate Symptom Score according to the American Urological Association (I-PSS), the influence on quality of life has been recorded by a quality of life questionnaire (LQ Index). Results:The I-PSS decreased by 41.4%, life quality improved by 46.1% during therapy. More than 96% of the patients reported no undesired side effects under the treatment with Prosta Fink Forte. Conclusion:Prosta Fink Forte facilitates an efficient improvement of BPH symptoms, especially in early stages.

Journal Section:
Original Article · Originalarbeit
This content is only available via PDF.
© 2000 S. Karger GmbH, Freiburg
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2000
You do not currently have access to this content.